EGFR Tyrosine Kinase Inhibitors Threonine-Tyrosine Kinase Inhibitors Serine-Threonine Kinase Inhibitors Kinase Inhibitors Chemotherapy DNA BCL Inhibitors PI3 Kinase Inhibitors Epigenetics | Pancreatic Ductal Adenocarcinoma | Non Small Cell Lung Cancer | Pancreatic Cancer | Hepatocellular Cancer | Pancreatic Adenocarcinoma | Thyroid Gland Medullary Carcinoma | Thyroid Gland Carcinoma | Colon Cancer | Thyroid Gland Anaplastic Carcinoma | Colorectal Cancer | Gastric Cancer |
---|---|---|---|---|---|---|---|---|---|---|---|
FOLFIRINOX | |||||||||||
gemcitabine + paclitaxel | |||||||||||
regorafenib | |||||||||||
cobimetinib | |||||||||||
sorafenib + BAY86-9766 | |||||||||||
selumetinib | |||||||||||
trametinib | |||||||||||
dasatinib + SCH772984 | |||||||||||
RTB101 + RAF265 | |||||||||||
dasatinib + selumetinib | |||||||||||
dasatinib | |||||||||||
cetuximab | |||||||||||
GSKJ4 | |||||||||||
panitumumab | |||||||||||
erlotinib | |||||||||||
imatinib | |||||||||||
sunitinib | |||||||||||
trametinib + dasatinib |